MPAM
RCKT icon

Monarch Partners Asset Management’s Rocket Pharmaceuticals RCKT Stock Holding History

Monarch Partners Asset Management’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$2.23M Buy
113,788
+27,003
+31% +$497K 0.66% 70
2022
Q3 		$1.39M Buy
+86,785
New +$1.35M 0.42% 115
2020
Q4 		– Sell
-26,090
Closed -$596K – 206
2020
Q3 		$596K Buy
26,090
+8,410
+48% +$207K 0.13% 141
2020
Q2 		$370K Buy
+17,680
New +$319K 0.09% 153
2018
Q4 		– Sell
-11,897
Closed -$293K – 203
2018
Q3 		$293K Sell
11,897
-3,085
-21% -$66.9K 0.03% 190
2018
Q2 		$294K Hold
14,982
– – 0.03% 187
2018
Q1 		$281K Buy
+14,982
New +$244K 0.03% 187

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.6B AUM 48.76% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return